Kun-Hsing Yu1, Jingjing Li, Michael Snyder, Gary M Shaw, Hugh M O'Brodovich. 1. aDepartment of Genetics bBiomedical Informatics Program cDepartment of Pediatrics, Stanford University School of Medicine, Stanford, California, USA *Kun-Hsing Yu and Jingjing Li contributed equally to the writing of this article.
Abstract
PURPOSE OF REVIEW: Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in premature infants. Twin studies have shown strong heritability underlying this disease; however, the genetic architecture of BPD remains unclear. RECENT FINDINGS: A number of studies employed different approaches to characterize the genetic aberrations associated with BPD, including candidate gene studies, genome-wide association studies, exome sequencing, integrative omics analysis, and pathway analysis. Candidate gene studies identified a number of genes potentially involved with the development of BPD, but the etiological contribution from each gene is not substantial. Copy number variation studies and three independent genome-wide association studies did not identify genetic variations significantly and consistently associated with BPD. A recent exome-sequencing study pointed to rare variants implicated in the disease. In this review, we summarize these studies' methodology and findings, and suggest future research directions to better understand the genetic underpinnings of this potentially life-long lung disease. SUMMARY: Genetic factors play a significant role in the development of BPD. Recent studies suggested that rare variants in genes participating in lung development pathways could contribute to BPD susceptibility.
PURPOSE OF REVIEW: Bronchopulmonary dysplasia (BPD) is a prevalent chronic lung disease in premature infants. Twin studies have shown strong heritability underlying this disease; however, the genetic architecture of BPD remains unclear. RECENT FINDINGS: A number of studies employed different approaches to characterize the genetic aberrations associated with BPD, including candidate gene studies, genome-wide association studies, exome sequencing, integrative omics analysis, and pathway analysis. Candidate gene studies identified a number of genes potentially involved with the development of BPD, but the etiological contribution from each gene is not substantial. Copy number variation studies and three independent genome-wide association studies did not identify genetic variations significantly and consistently associated with BPD. A recent exome-sequencing study pointed to rare variants implicated in the disease. In this review, we summarize these studies' methodology and findings, and suggest future research directions to better understand the genetic underpinnings of this potentially life-long lung disease. SUMMARY: Genetic factors play a significant role in the development of BPD. Recent studies suggested that rare variants in genes participating in lung development pathways could contribute to BPD susceptibility.
Authors: Hui Wang; Krystal R St Julien; David K Stevenson; Thomas J Hoffmann; John S Witte; Laura C Lazzeroni; Mark A Krasnow; Cecele C Quaintance; John W Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; Gary M Shaw; Hugh M O'Brodovich Journal: Pediatrics Date: 2013-07-29 Impact factor: 7.124
Authors: Jingjing Li; Kun-Hsing Yu; John Oehlert; Laura L Jeliffe-Pawlowski; Jeffrey B Gould; David K Stevenson; Michael Snyder; Gary M Shaw; Hugh M O'Brodovich Journal: Am J Respir Crit Care Med Date: 2015-09-01 Impact factor: 21.405
Authors: Matthew T Maurano; Richard Humbert; Eric Rynes; Robert E Thurman; Eric Haugen; Hao Wang; Alex P Reynolds; Richard Sandstrom; Hongzhu Qu; Jennifer Brody; Anthony Shafer; Fidencio Neri; Kristen Lee; Tanya Kutyavin; Sandra Stehling-Sun; Audra K Johnson; Theresa K Canfield; Erika Giste; Morgan Diegel; Daniel Bates; R Scott Hansen; Shane Neph; Peter J Sabo; Shelly Heimfeld; Antony Raubitschek; Steven Ziegler; Chris Cotsapas; Nona Sotoodehnia; Ian Glass; Shamil R Sunyaev; Rajinder Kaul; John A Stamatoyannopoulos Journal: Science Date: 2012-09-05 Impact factor: 47.728
Authors: Thomas J Hoffmann; Gary M Shaw; David K Stevenson; Hui Wang; Cecele C Quaintance; John Oehlert; Laura L Jelliffe-Pawlowski; Jeffrey B Gould; John S Witte; Hugh M O'Brodovich Journal: Am J Med Genet A Date: 2014-06-26 Impact factor: 2.802
Authors: Namasivayam Ambalavanan; C Michael Cotten; Grier P Page; Waldemar A Carlo; Jeffrey C Murray; Soumyaroop Bhattacharya; Thomas J Mariani; Alain C Cuna; Ona M Faye-Petersen; David Kelly; Rosemary D Higgins Journal: J Pediatr Date: 2014-11-06 Impact factor: 4.406
Authors: Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean Journal: Nature Date: 2012-11-01 Impact factor: 49.962
Authors: Bernard Thébaud; Kara N Goss; Matthew Laughon; Jeffrey A Whitsett; Steven H Abman; Robin H Steinhorn; Judy L Aschner; Peter G Davis; Sharon A McGrath-Morrow; Roger F Soll; Alan H Jobe Journal: Nat Rev Dis Primers Date: 2019-11-14 Impact factor: 52.329
Authors: Wes Onland; Maruschka P Merkus; Debbie H Nuytemans; Marijke C Jansen-van der Weide; Rebecca Holman; Anton H van Kaam Journal: Trials Date: 2018-03-09 Impact factor: 2.279
Authors: Aaron Hamvas; Rui Feng; Yingtao Bi; Fan Wang; Soumyaroop Bhattacharya; Jared Mereness; Madhurima Kaushal; C Michael Cotten; Philip L Ballard; Thomas J Mariani Journal: BMC Genet Date: 2018-10-20 Impact factor: 2.797